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ffect of papaya leaf extract on platelet count in dengue fever:
randomized controlled trial (PLEAD Trial)
.Z.K. Assir, H. Mansoor, T. Waseem ∗, H.I. Ahmed, S.K. Bukhari, J.
kram
Allama Iqbal Medical College/ Jinnah Hospital Lahore, Lahore, Punjab,
akistan
Background: Thrombocytopenia is a prominent feature of
engue fever and dengue hemorrhagic fever. Papaya leaves have
een used by many patients due to their perceived beneﬁcial effect
n platelet count. However, scientiﬁc data on this beneﬁcial effect
s lacking.
Methods: A single centre, single blinded, randomized placebo
ontrolled trial was conducted at the Department of Medicine, Jin-
ah Hospital Lahore. Adult patients admitted with diagnosis of
engue fever (DF) or dengue hemorrhagic fever (DHF) and platelet
ounts ≤50×109/L were eligible for the study. After obtaining
ritten informed consent participants were randomly assigned to
ither treatment or control group. 5ml of papaya leaf extract in
yrup form was given twice daily for four days to treatment group
nd placebo solution was given to control group. Platelet counts
ere checked on daily basis. Outcome was measured in terms of
latelet increments from baseline.
Results: Thirty-nine (39) patients were enrolled and 28 (72%)
ere male. 19 (48.7%) patients received papaya leaf extract.
ean baseline platelet counts of treatment and control group
ere comparable, 36.2×109/L and34.1×109/L respectively.Mean
latelet counts at the end of treatment were 142.3×109/L
nd 116.5×109/L in treatment and control group respectively
p=0.182). Platelet count normalized (i.e. ≥150×109/L) in 9
47.4%) patients in treatment group and 5 (25%) patients in con-
rol group (p=0.191). Similarly, no signiﬁcant differences in mean
latelet count increments frombaselinewere foundbetween treat-
ent and control group on day 2 (23.7×109/L vs 15.9×109/L,
= 0.242), day 3 (42.6×109/L vs 35.1×109/L, p =0.424), day 4
71.6×109/L vs 58.4×109/L, p =0.309) and day 5 (106×109/L vs
2.3×109/L, p =0.189). No signiﬁcant adverse event occurred in
ither group.Conclusion: Papaya leaf extract, in this study, did not show any
ffect on platelet count in dengue fever.
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Background: Dengue viruses are transmitted by container-
inhabiting Aedes (Stegomyia) mosquitoes, primarily Aedes aegypti
and alsoAedes albopictus. After femalemosquitoes acquire the virus
when taking blood from an infected human host, they use a vari-
ety of cues to identify potential oviposition sites, where they must
deposit eggs before taking another bloodmeal. For several years,we
haveworked to identify those semiochemical cues and to develop a
more effective lethal ovitrap (Attractive Lethal OviTrap=ALOT) for
Ae. aegypti control, with concentration on oviposition attractants
and stimulants. Here we describe the ALOT, as well as focus group
and modeling work designed to identify important trap attributes.
Wewill alsopresent entomological anddengue incidencedata from
an ongoing ﬁeld trial in Iquitos, Peru.
Methods: Methods to be discussed include large cage trials,
and ﬁeld trials comparing areas with ALOTs to those without. In
cage trials, efﬁcacy endpoints included mortality, eggs oviposited
in the ALOT and eggs retained by dead females. In small scale ﬁeld
trials, efﬁcacy endpoints included eggs deposited in non-lethal ovi-
traps, number of female mosquitoes collected, and female gravid
and parous status. In the large scale ﬁeld trial, efﬁcacy is measured
by entomological indices (adult index, etc.), by gravid and parous
status of female mosquitoes, and by dengue incidence.
Results: In large cage trails we consistently have shown 90-98%
efﬁcacy of the ALOT compared to normal ovitraps and to typi-
cal backyard containers; in two ﬁeld trials based in New Orleans,
Louisiana, we have shown that there are signiﬁcantly fewer gravid
and parous females in areas treated with ALOTs, as compared to
untreated areas. Currently, in Iquitos, Peru we are conducting a
large scale efﬁcacy trial to assess the ability of the ALOT to reduce
dengue transmission.
Conclusion: Our results suggest that the ALOT can impact virus
transmission because it reduces the number of epidemiologically
important (e.g., previously blood-fed) mosquitoes. The ALOT is not
designed to be a stand-alone tool for dengue vector control; it
should be used as part of an integrated management program
(e.g., source reduction, active case surveillance, targeted insecticide
treatment, etc).
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